BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022
HIV Med
.
2022 Dec:23 Suppl 5:3-115.
doi: 10.1111/hiv.13446.
Authors
Laura Waters
1
,
Alan Winston
2
,
Iain Reeves
3
,
Marta Boffito
4
,
Duncan Churchill
5
,
Ben Cromarty
6
,
David Dunn
7
,
Douglas Fink
7
,
Sarah Fidler
2
,
Caroline Foster
8
,
Julie Fox
9
,
Ravi Gupta
10
,
Andy Hilton
11
,
Saye Khoo
12
,
Clifford Leen
13
,
Nicola Mackie
8
,
Nadia Naous
4
,
Daisy Ogbonmwan
14
,
Chloe Orkin
15
,
Linda Panton
16
,
Frank Post
17
,
Anton Pozniak
4
,
Caroline Sabin
7
,
John Walsh
8
Affiliations
1
Central and North West London NHS Foundation Trust
2
Imperial College London and Imperial College Healthcare NHS Trust, London
3
Homerton Hospital NHS Trust, London
4
Chelsea and Westminster Hospital NHS Foundation Trust, London
5
University Hospitals Sussex NHS Foundation Trust
6
UK Community Advisory Board and Yorkshire Mesmac
7
University College London
8
Imperial College Healthcare NHS Trust, London
9
Guys and St Thomas’ NHS Foundation Trust and Kings College London
10
University of Cambridge
11
UK Community Advisory Board and HiVitality
12
University of Liverpool
13
NHS Lothian
14
University Hospital North Durham, Durham
15
Queen Mary University of London
16
Western General Hospital, Edinburgh
17
King's College Hospital NHS Foundation Trust, London
PMID:
36504313
DOI:
10.1111/hiv.13446
No abstract available
MeSH terms
Adult
Anti-Retroviral Agents / therapeutic use
HIV Infections* / drug therapy
HIV Seropositivity*
HIV-1*
Humans
Substances
Anti-Retroviral Agents